Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial replacement therapies are therapeutic strategies that involve introducing beneficial or benign bacterial strains into a host environment to displace or outcompete pathogenic bacteria. This approach aims to restore microbial balance and prevent or treat various diseases by leveraging natural competition among microbial species within human microbiomes. Modalities include probiotics, fecal microbiota transplantation (FMT), and the use of engineered or selected niche competitors.
Competitive exclusion, direct antagonism (e.g., bacteriocin production), and/or immune modulation by introduced bacterial strains.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Replacement Therapies.